share_log

Applied DNA Sciences (NASDAQ:APDN) Posts Earnings Results, Beats Expectations By $0.19 EPS

Applied DNA Sciences (NASDAQ:APDN) Posts Earnings Results, Beats Expectations By $0.19 EPS

應用DNA科學公司(納斯達克代碼:APDN)公佈盈利業績,每股收益超出預期0.19美元
Financial News Live ·  2022/08/14 22:41

Applied DNA Sciences (NASDAQ:APDN – Get Rating) posted its quarterly earnings data on Thursday. The technology company reported ($0.13) earnings per share for the quarter, topping analysts' consensus estimates of ($0.32) by $0.19, Fidelity Earnings reports. Applied DNA Sciences had a negative return on equity of 148.50% and a negative net margin of 68.79%.

應用DNA科學公司(納斯達克代碼:APDN-GET Rating)週四公佈了季度收益數據。富達收益報告顯示,這家科技公司公佈了本季度每股收益(0.13美元),比分析師普遍預期的每股收益(0.32美元)高0.19美元。應用DNA科學公司的淨資產回報率為負148.50%,淨利潤率為負68.79%。

Applied DNA Sciences Price Performance

應用DNA科學的價格表現

APDN traded down $0.82 on Friday, reaching $3.70. 4,027,208 shares of the stock were exchanged, compared to its average volume of 20,774,652. The company's 50-day moving average price is $1.53 and its 200 day moving average price is $1.89. Applied DNA Sciences has a fifty-two week low of $0.62 and a fifty-two week high of $7.35. The firm has a market capitalization of $44.33 million, a PE ratio of -2.33 and a beta of 1.26.

上週五,APDN股價下跌0.82美元,至3.70美元。該股成交量為4,027,208股,而平均成交量為20,774,652股。該公司的50日移動均線價格為1.53美元,200日移動均線價格為1.89美元。應用DNA科學公司的股價跌至0.62美元的52周低點和7.35美元的52周高點。該公司市值為4433萬美元,市盈率為-2.33,貝塔係數為1.26。

Get
到達
Applied DNA Sciences
應用DNA科學
alerts:
警報:

Analyst Upgrades and Downgrades

分析師升級和下調評級

Separately, HC Wainwright lowered their price target on Applied DNA Sciences from $6.00 to $4.00 and set a "na" rating for the company in a research report on Monday, May 16th.

另外,在5月16日週一的一份研究報告中,HC Wainwright將其對應用DNA科學的目標價從6.00美元下調至4.00美元,並將該公司的評級定為“NA”。

Institutional Trading of Applied DNA Sciences

應用DNA科學的制度性交易

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Virtu Financial LLC purchased a new position in shares of Applied DNA Sciences during the 1st quarter valued at about $49,000. State Street Corp raised its stake in shares of Applied DNA Sciences by 53.6% during the 1st quarter. State Street Corp now owns 26,977 shares of the technology company's stock valued at $58,000 after buying an additional 9,416 shares during the last quarter. Atria Wealth Solutions Inc. purchased a new position in shares of Applied DNA Sciences during the 1st quarter valued at about $67,000. Finally, Dimensional Fund Advisors LP raised its stake in shares of Applied DNA Sciences by 53.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 65,916 shares of the technology company's stock valued at $141,000 after buying an additional 22,843 shares during the last quarter. Institutional investors and hedge funds own 8.24% of the company's stock.
機構投資者和對衝基金最近增持或減持了該公司的股份。Virtu Financial LLC在第一季度購買了應用DNA科學公司的新頭寸,價值約49,000美元。道富集團在第一季度增持了應用DNA科學公司的股份53.6%。道富集團目前持有26,977股這家科技公司的股票,價值58,000美元,此前在上個季度又購買了9,416股。Atria Wealth Solutions Inc.在第一季度購買了一股新的應用DNA科學公司股票,價值約6.7萬美元。最後,Dimension Fund Advisors LP在第一季度將其在應用DNA Science的股份增加了53.0%。Dimension Fund Advisors LP現在擁有這家科技公司65,916股股票,價值141,000美元,上個季度又購買了22,843股。機構投資者和對衝基金持有該公司8.24%的股份。

Applied DNA Sciences Company Profile

應用DNA科學公司簡介

(Get Rating)

(獲取評級)

Applied DNA Sciences, Inc develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection for various applications used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNify IF portable DNA readers and SigNify consumable reagent test kits that provide real-time authentication of molecular tags in the field; and CertainT, which indicates the use of tagging, testing, and tracking platforms and solutions enabling manufacturers, brands, and trade organizations to convey proof of their product claims.

應用DNA科學公司開發和銷售基於DNA的技術解決方案,用於基於核酸的體外診斷和基於臨牀前核酸的藥物開發和製造市場;以及用於供應鏈安全、防偽和防盜技術目的。該公司的供應鏈安全和產品認證解決方案包括簽名分子標籤,它為用於加強品牌保護努力和加強供應鏈安全的各種應用提供法醫力量和保護,以及標記、跟蹤和定罪罪犯;標誌便攜式DNA讀取器和消耗品試劑檢測試劑盒,提供現場分子標籤的實時身份驗證;以及確定性,表明使用了標籤、測試和跟蹤平臺和解決方案,使製造商、品牌和貿易組織能夠傳達其產品聲明的證據。

Read More

閲讀更多內容

  • Get a free copy of the StockNews.com research report on Applied DNA Sciences (APDN)
  • MarketBeat: Week in Review 8/8 – 8/12
  • 2 Important Retail Stock Battles to Watch
  • What Is WallStreetBets and What Stocks Are They Targeting?
  • Institutions And Analysts Propel Jack In The Box Higher
  • Can You Guess Which EV Stock Is Beating Tesla ?
  • 免費獲取StockNews.com關於應用DNA科學的研究報告(APDN)
  • MarketBeat:回顧中的一週2012-8-8
  • 值得關注的兩場重要的零售股大戰
  • 什麼是WallStreetBets,他們的目標是什麼股票?
  • 機構和分析師推動Jack in the Box走高
  • 你能猜到哪個電動車股票打敗了特斯拉嗎?

Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

獲得《應用DNA科學日報》的新聞和評級-在下面輸入您的電子郵件地址,以通過MarketBeat.com的免費每日電子郵件時事通訊接收對應用DNA科學和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論